Equities

Smith & Nephew PLC

SN.:LSE

Smith & Nephew PLC

Health CareMedical Equipment and Services
  • Price (GBX)976.00
  • Today's Change1.20 / 0.12%
  • Shares traded1.50m
  • 1 Year change-4.50%
  • Beta0.9528
Data delayed at least 20 minutes, as of Nov 21 2024 15:48 GMT.
More ▼

Profile data is unavailable for this security.

About the company

Smith & Nephew plc is a portfolio medical technology company. The Company is engaged in developing, manufacturing, marketing, and selling medical devices and services. It is focused on the repair, regeneration, and replacement of soft and hard tissue. Its segments include Orthopaedics, Sports Medicine & ENT and Advanced Wound Management. Its Orthopaedics segment includes a range of hip and knee Implants used to replace diseased, damaged or worn joints, robotics-assisted and digital enabling technologies and services that help surgeons, and trauma products used to stabilize severe fractures and correct hard tissue deformities. Its Sports Medicine & Ear, Nose and Throat (ENT) businesses offer advanced products and instruments used to repair or remove soft tissue. Its Advanced Wound Management portfolio provides a comprehensive set of products to meet broad and complex clinical needs, and to help healthcare professionals reduce the human and economic consequences of wounds.

  • Revenue in GBP (TTM)4.46bn
  • Net income in GBP241.11m
  • Incorporated1937
  • Employees18.00k
  • Location
    Smith & Nephew PLCBuilding 5, Croxley Park, Hatters LaneWATFORD WD18 8YEUnited KingdomGBR
  • Phone+44 20 7401 7646Fax+44 20 7930 3353
  • Websitehttps://www.smith-nephew.com/
More ▼

Mergers & acquisitions

Acquired companyDeal statusDateDate /
Deal status		SN.:LSE since
announced		Transaction
value
Cartiheal 2009 LtdDeal completed22 Nov 202322 Nov 2023Deal completed-4.50%330.00m
Data delayed at least 20 minutes, as of Nov 21 2024 15:48 GMT.

Peer analysis

CompanyRevenue (TTM)Net income (TTM)Market capEmployeesMarket Cap /
Employees
Amplifon SpA1.96bn129.70m4.38bn14.38k4.38bn14.38k
ConvaTec Group PLC1.75bn121.72m4.75bn10.13k4.75bn10.13k
DiaSorin SpA-83.20bn-83.20bn4.85bn3.19k4.85bn3.19k
Demant A/S2.50bn295.40m6.36bn21.50k6.36bn21.50k
Smith & Nephew plc4.48bn242.33m8.58bn18.00k8.58bn18.00k
BioMerieux SA3.17bn342.21m9.50bn14.65k9.50bn14.65k
Sartorius AG2.77bn69.22m11.59bn13.76k11.59bn13.76k
Data as of Nov 21 2024. Currency figures normalised to Smith & Nephew PLC's reporting currency: UK Pound GBX

Institutional shareholders

37.13%Per cent of shares held by top holders
HolderShares% Held
UBS Asset Management (UK) Ltd.as of 01 Nov 202455.80m6.38%
BlackRock Investment Management (UK) Ltd.as of 16 Feb 202445.46m5.20%
Cevian Capital ABas of 02 Jul 202443.90m5.02%
Wellington Management Co. LLPas of 31 Dec 202042.67m4.88%
The Vanguard Group, Inc.as of 01 Nov 202438.53m4.41%
Norges Bank Investment Managementas of 28 Jun 202426.70m3.05%
BlackRock Fund Advisorsas of 01 Nov 202422.36m2.56%
Walter Scott & Partners Ltd.as of 01 Nov 202418.85m2.16%
Threadneedle Asset Management Ltd.as of 01 Nov 202415.47m1.77%
Legal & General Investment Management Ltd.as of 01 Nov 202414.88m1.70%
More ▼
Data from 30 Jun 2024 - 30 Sep 2024Source: FactSet Research Systems Inc.
Data Provided by LSEG
All markets data located on InvestorsChronicle.co.uk is subject to the Investors Chronicle Terms & Condition
All content on InvestorsChronicle.co.uk is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by IC and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via Investors Chronicle is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. Investors Chronicle is not responsible for any use of content by you outside its scope as stated in the Investors Chronicle Terms & Condition.